Browse Drug Recalls

45 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 45 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 45 FDA drug recalls.

Clear
DateProductReasonClassFirm
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-51... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 6787... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Sep 19, 2025 Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Aug 28, 2025 Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by:... Superpotent drug Class II Ascend Laboratories, LLC
Jul 21, 2025 Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx... Failed Dissolution Specifications: low dissolution results Class II Ascend Laboratories, LLC
Jul 9, 2025 Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only,... CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended ... Class II Ascend Laboratories, LLC
Jul 9, 2025 Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only... CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended ... Class II Ascend Laboratories, LLC
May 23, 2025 Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx... Failed Impurities/Degradation Specifications An out-of-specification result was observed in the r... Class II Ascend Laboratories, LLC
May 23, 2025 Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx... Failed Impurities/Degradation Specifications An out-of-specification result was observed in the r... Class II Ascend Laboratories, LLC
Dec 12, 2024 Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured... CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit Class II Ascend Laboratories, LLC
Dec 12, 2024 Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured... CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit Class II Ascend Laboratories, LLC
Sep 3, 2024 Mycophenolic Acid Delayed-Release Tablets USP, 360 mg, Rx Only, 120 Tablets p... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Jan 16, 2024 Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of... Failed Impurities/Degradation Specification: Out of specification for organic impurities Class II Ascend Laboratories, LLC
Dec 29, 2023 Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle... Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an ... Class II Ascend Laboratories, LLC
Jul 18, 2023 Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, ... Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organ... Class III Ascend Laboratories, LLC
Jul 11, 2023 Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Mar 17, 2023 Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manuf... Out of specification (OOS) for Spectroscopic Identification test by IR. Class II Ascend Laboratories, LLC
Mar 14, 2023 Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufa... CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Da... Class II Ascend Laboratories, LLC
Mar 14, 2023 Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle,... CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Da... Class II Ascend Laboratories, LLC
Jan 5, 2023 Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablet... Failed Dissolution Specification Class II Ascend Laboratories, LLC
Jan 5, 2023 Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 100 Tablet... Failed Dissolution Specification Class II Ascend Laboratories, LLC
Jan 5, 2023 Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablet... Failed Dissolution Specification Class II Ascend Laboratories, LLC
Dec 28, 2022 Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 678... Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on th... Class II Ascend Laboratories, LLC
Jan 12, 2022 Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Table... Failed Dissolution Specifications. Class II Ascend Laboratories, LLC
Dec 21, 2021 Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem ... Failed impurities/degradation specifications Class II Ascend Laboratories, LLC
Apr 12, 2021 Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Susp... Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detec... Class II Preferred Pharmaceuticals, Inc.
Jan 22, 2021 Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx On... CGMP Deviations: Individual Unidentified impurities results of the product was found at higher si... Class II Ascend Laboratories LLC
Jan 22, 2021 Cephalexin for Oral Suspension, USP 250 mg per 5 mL, 100 ml (when mixed) Rx O... CGMP Deviations: Individual Unidentified impurities results of the product was found at higher si... Class II Ascend Laboratories LLC
Dec 17, 2020 Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL ... Failed Impurity/Degradation Specifications Class II Ascend Laboratories LLC
Dec 17, 2020 Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL ... Failed Impurity/Degradation Specifications Class II Ascend Laboratories LLC
Nov 24, 2020 Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by... Failed Dissolution Specifications; Out of Specification (low) results were obtained. Class II Ascend Laboratories LLC
Jan 24, 2020 Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactu... cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API sour... Class II Ascend Laboratories LLC
Jan 22, 2020 Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bo... Failed Dissolution Specifications: low out of specification results for dissolution testing. Class III Ascend Laboratories LLC
Jul 19, 2019 Atorvastatin Calcium Tablet USP 80 mg, a) 90 count (NDC 67877-0514-90) and b)... Failed Dissolution Specifications Class II Ascend Laboratories LLC
Jul 16, 2019 Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07)... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Jul 16, 2019 Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-0... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Jul 16, 2019 Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Jul 16, 2019 Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Jul 16, 2019 Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-0... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Jul 16, 2019 Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-0... CGMP Deviations: product was manufactured that did not prevent possible cross contamination with ... Class II Deva Holding AS - Cerkezkoy Subesi
Feb 22, 2019 Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, M... Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed du... Class II Ascend Laboratories LLC
Nov 14, 2018 Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by:... Presence of Foreign Substance; metal shard found in tablet Class II Ascend Laboratories LLC
May 5, 2017 AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactu... PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled w... Class III Ascend Laboratories LLC
Nov 2, 2016 Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactu... Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of... Class II Ascend Laboratories LLC

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.